Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Safety of High Flow Nasal Cannula and Noninvasive Ventilation for Treatment of Patients With COVID-19 Complicated by Respiratory Failure

NCT04452708 is registered in ClinicalTrials.gov with Chinese University of Hong Kong as lead sponsor.

NCT NCT04452708
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04452708 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Safety of High Flow Nasal Cannula and Noninvasive Ventilation for Treatment of Patients With COVID-19 Complicated by Respiratory Failure
Lead sponsor
Chinese University of Hong Kong
Phase
Observational
Overall status
Completed
Start date
June 11, 2020
Completion date
April 30, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

respiratory failure